Lyell Immunopharma (LYEL) Return on Sales Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 4.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.00 |
| 10 | Lyell Immunopharma | 373.31 Mn | 373.31 Mn | - | -13,390.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13,390.00 |
| Dec 31, 2025 | -2,989.00 |
| Sep 30, 2025 | -956.00 |
| Jun 30, 2025 | -2,009.00 |
| Mar 31, 2025 | 8,608.00 |
| Dec 31, 2024 | -13,806.00 |
| Sep 30, 2024 | 787.00 |
| Jun 30, 2024 | -1,228.00 |
| Mar 31, 2024 | -15,359.00 |
| Dec 31, 2023 | -4,032.00 |
| Sep 30, 2023 | 19,298.00 |
| Jun 30, 2023 | -2,245.00 |
| Mar 31, 2023 | -770.00 |
| Dec 31, 2022 | 16.00 |
| Sep 30, 2022 | -21,378.00 |
| Jun 30, 2022 | 23.00 |
| Mar 31, 2022 | -101.00 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 16.00 |
| Jun 30, 2021 | 9.00 |